Josh Snyder - Concepedia

Author

Josh Snyder

Astellas Pharma (United States)

Also Known As

Josh Snyder, Josh T. Snyder, Snyder, Josh, Snyder, Josh T.

Publications

468

Citations

H-Index

Concepts

All Affiliations

Astellas Pharma (United States)University of Santa Monica

About

Josh Snyder is an author at Astellas Pharma (United States) specializing in medicine, drug discovery, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	116
2	Engineering	2	2	132
3	Biochemistry	1	1	33
4	Biomolecular Engineering	1	1	45
5	Computer Engineering	1	1	87

Josh Snyder

Publications

467

Citations

H-Index

Page 1

	Year	Citations
Modulation of Macropinocytosis-Mediated Internalization Decreases Ocular Toxicity of Antibody–Drug Conjugates Hui Zhao, John Atkinson, Sara Gulesserian, Cancer Research	2018	120
GPT-4o System Card OpenAI, A. M. Hurst, Adam Lerer, arXiv (Cornell University) Artificial IntelligenceEngineeringMachine LearningSpeech RecognitionNatural Language Processing	2024	87
Development of ASG-15ME, a Novel Antibody–Drug Conjugate Targeting <i>SLITRK6</i> , a New Urothelial Cancer Biomarker Kendall Morrison, Pia M. Challita-Eid, Arthur Raitano, Molecular Cancer Therapeutics	2016	65
Inhibition of Megakaryocyte Differentiation by Antibody–Drug Conjugates (ADCs) is Mediated by Macropinocytosis: Implications for ADC-induced Thrombocytopenia Hui Zhao, Sara Gulesserian, Sathish Kumar Ganesan, Molecular Cancer Therapeutics	2017	63
Investigation of Hydrophilic Auristatin Derivatives for Use in Antibody Drug Conjugates Brian A. Mendelsohn, Stuart D. Barnscher, Josh Snyder, Bioconjugate Chemistry Pharmaceutical ScienceEngineeringPyridine DerivativePharmaceutical ChemistryMedicinal Chemistry	2017	45
Preclinical Evaluation of an Anti-Nectin-4 ImmunoPET Reagent in Tumor-Bearing Mice and Biodistribution Studies in Cynomolgus Monkeys Dean O. Campbell, Akihiro Noda, Alla Verlinsky, Molecular Imaging and Biology InflammationCynomolgus MonkeysAnti-nectin-4 Immunopet ReagentImmunologyTumor Immunity	2016	38
Metabolism of an Oxime-Linked Antibody Drug Conjugate, AGS62P1, and Characterization of Its Identified Metabolite Josh Snyder, Maria-Christina Malinao, Julien Dugal‐Tessier, Molecular Pharmaceutics Oxime-linked AdcMetabolomic ProfilingOxime Upon ConjugationCancer BiologyTumor Biology	2018	33
AGS62P1, a Novel Anti-FLT3 Antibody Drug Conjugate, Employing Site Specific Conjugation, Demonstrates Preclinical Anti-Tumor Efficacy in AML Tumor and Patient Derived Xenografts Nandini Rudra-Ganguly, Christine Lowe, Cyrus Virata, Blood	2015	16

Page 1